Symmetry Technologies Inc. moves to lab test and develop its "Inducible Expression System for Biosynthetic Production of Testerone in Men"
October 07, 2013 08:00 ET
|
Symmetry Technologies Inc.
Houston, TX, Oct. 7, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (SMMR). is pleased to announce that
it has initiated contact with a US based BioScience research and
testing facility in its...
Symmetry Technologies Inc. acquires the rights to a ground breaking technology that produces Biosynthetic Testosterone in men from A Houston PhD led Biomedical research firm. Technology estimated value up to 10 Billion Dollars.
August 14, 2013 16:00 ET
|
Symmetry Technologies Inc.
Houston,TX, Aug. 14, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to
announce the acquisition from a Houston, PhD led Biomedical
research firm, all work...
Symmetry Technologies Inc. licenses a Human Rejuvenation Nutraceutical product from an FDA compliant laboratory. It will sell under the name "Resurgencell" in the yearly $200 billion USD Nutraceutical market
August 01, 2013 16:00 ET
|
Symmetry Technologies Inc.
Houston,Tx, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Symmetry Technologies Inc. (OTC:SMMR) is pleased to
announce that it has licensed a Human Rejuvenation Nutraceutical
product for retail sale from a US...